COMMUNIQUÉS West-GlobeNewswire

Innovation Pharmaceuticals Concludes Successful Phase 2a Trial of Kevetrin for Ovarian Cancer; Intra-Tumor Modulation of p53 Observed
08/02/2018
BEVERLY, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals Inc., (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announces the closure of its Phase 2a clinical trial ( [...]
Kura Oncology to Present at the Leerink Partners 7th Annual Global Healthcare Conference
08/02/2018
SAN DIEGO, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA ), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced its [...]
Navamedic ASA: Invitation to presentation of fourth quarter 2017
08/02/2018
Navamedic ASA invites you to a presentation of the fourth quarter 2017 figures. The presentation will take place at Felix Konferansesenter, Aker Brygge, Oslo, Thursday 15 February. The presentation will start at 08.00 [...]
Anavex Life Sciences to Present at the 2018 BIO CEO & Investor Conference
08/02/2018
NEW YORK, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL ), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of [...]
Millennium Blockchain Signs Letter-of-Intent to Invest $5 Million Into Healthcare Blockchain Company BurstIQ at #DAVOS2018
08/02/2018
Blockchain division negotiates first placement in Healthcare data blockchain use-case sector LAS VEGAS, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Millennium Blockchain Inc. (OTC:MBLC) (“Millennium Blockchain” or the “Company [...]
Resverlogix Highlights Key Accomplishments and 2018 Targets
08/02/2018
CALGARY, Alberta, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX ) highlighted today recent key accomplishments and 2018 targets. Recent Accomplishments The Company has [...]
Neuralstem to Participate at The Young Jewish Professionals CEO Healthcare Symposium
08/02/2018
GERMANTOWN, Md., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq: CUR ), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that Richard Daly, Chairman and [...]
Proteostasis Therapeutics to Present at the LEERINK Partners 7th Annual Global Healthcare Conference
08/02/2018
CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI ), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to [...]
Edge Therapeutics to Present at Upcoming Investor Conferences in February
08/02/2018
BERKELEY HEIGHTS, N.J., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq: EDGE ), a clinical-stage biotechnology company developing novel hospital-based therapies for the management of acute, life- [...]
Adventist Health Promotes Dustin Aho to VP of Mission Integration
08/02/2018
ROSEVILLE, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Adventist Health —a non-profit integrated health system serving more than 75 communities on the West Coast and Hawaii—is proud to announce the recent promotion of [...]
VBL Therapeutics Receives Milestone Payment From NanoCarrier Under Licensing Agreement for VB-111 in Japan
08/02/2018
- Per agreement, milestone payments can exceed $100 million, in addition to double-digit million tiered royalties - TEL AVIV, Israel, Feb. 08, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ) today announces [...]
Madrigal’s MGL-3196 Achieves Primary Endpoint in Patients with Heterozygous Familial Hypercholesterolemia (HeFH)
08/02/2018
-- Statistically significant improvement achieved in the reduction of LDL cholesterol (LDL-C) with MGL-3196 compared to placebo, the primary endpoint of this 12-week Phase 2 clinical trial in HeFH patients on maximal [...]
Cambrex Reports Fourth Quarter and Full Year 2017 Financial Results
08/02/2018
- Net Revenue increased 2.5% for the fourth quarter and 9% for the full year 2017- - Conference call at 8:30 a.m. ET on February 8, 2018 - EAST RUTHERFORD, N.J., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation ( [...]
Emergent BioSolutions to Release Fourth Quarter and Full Year 2017 Financial Results and Conduct a Conference Call on February 22, 2018
08/02/2018
GAITHERSBURG, Md., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) will host a conference call on Thursday, February 22, 2018 at 5:00 pm (Eastern Time) to discuss the financial results for the [...]
National Institutes of Health (NIH) Announces NIAGEN® Prevents Neurological Damage and Shows Improved Cognitive and Physical Function in a Mouse Model of Alzheimer’s Disease
08/02/2018
IRVINE, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that the results from its [...]
RECORDATI: PRELIMINARY 2017 RESULTS CONFIRM CONTINUED GROWTH OF SALES AND PROFITABILITY. SALES +11.6%, OPERATING INCOME +24.1%, NET INCOME +21.6%
08/02/2018
Consolidated revenues € 1,288.1 million, +11.6%. EBITDA (1) € 454.7 million, +22.5% Operating income € 406.5 million, +24.1%. Net income € 288.8 million, +21.6%. Net financial position (2) : net debt of € 381.8 million [...]
OraSure Technologies to Present at the LEERINK 7th Annual Global Healthcare Conference
08/02/2018
BETHLEHEM, Pa., Feb. 08, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, [...]
Onconova Therapeutics Announces Pricing of $8.7 Million Underwritten Public Offering
08/02/2018
NEWTOWN, Pa., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ) (“Onconova” or “we”), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug [...]
Sanofi Commences Tender Offer for Acquisition of Bioverativ Inc.
08/02/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi Commences Tender Offer for Acquisition of Bioverativ Inc. Paris - February 8, 2018 - Sanofi announced today that on February 7, 2018 it commenced a tender [...]

Pages